| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $3.5M | — | -17.5% |
| SG&A Expense | $2.1M | — | -6.5% |
| Operating Income | -$5.6M | — | +13.6% |
| Income Tax | $0 | — | — |
| Net Income | $5.0M | — | +198.7% |
| EPS (Basic) | $0.31 | — | +186.1% |
| EPS (Diluted) | $0.30 | — | +183.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.2M | -29.1% | -35.0% |
| Short-term Investments | $0 | -100.0% | -100.0% |
| Current Assets | $8.6M | -36.8% | -66.1% |
| Total Assets | $8.6M | -36.7% | -66.0% |
| Current Liabilities | $5.3M | +40.5% | +19.2% |
| Total Liabilities | $9.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.9M | — | +0.5% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $1.5M | — | +220.7% |
| Financing Cash Flow | $0 | — | -100.0% |
| Free Cash Flow | -$4.9M | — | +0.6% |
| -32.8% |
| Stockholders' Equity | -$1.1M | +83.4% | -110.1% |